baber/WOPTO huggingface dataset:
Patent AU-2011312232-B2 (AU)
Title: Non-invasive breathing assistance apparatus and method
Inventor: VARGA CHRISTOPHER M
IPC: A61M11/02
Filed: 2011-10-04
Granted: 2016-08-11
Abstract: An nCPAP device for assisting patient breathing includes a generator body forming an inlet, a chamber, and first and second flow circuits. The chamber directs pressurized gas from the inlet to the flow circuits. The flow circuits each include a nozzle, a channel, and at least one port. The nozzle emits a jet stream into the channel in a direction of a patient side thereof. The port fluidly connects the channel to ambient, and promotes entrainment of ambient air with the jet stream. In some embodiments, the channel forms a ramp feature directing exhaled air toward the jet stream in an angular fashion. The generator body requires reduced driving pressures to achieve target CPAP levels and reduces total imposed WOB as compared to conventional designs.
Patent AU-2011318449-B2 (AU)
Title: Modular shell for crusher device
Inventor: LOYER HAROLD B
IPC: B02C2/00
Filed: 2011-09-30
Granted: 2014-02-13
Abstract: A modular bottom shell of a multi-shell crusher device, the shell includes a central hub having a centered cylindrical support hole and at least two support arms extending orthogonally from the centered cylindrical support hole, each support arm having an end plate, and wherein at least one of the two support arms has an orthogonal bore therein which extends from within the centered cylindrical support hole to an outer portion of the support arm; and at least two outer shell sections having an annular inner surface, and wherein each of the outer shell sections has an upper surface and a lower surface, the upper and lower surfaces extending from one end of the outer shell section to the other end of the outer shell.
Patent AU-2011335901-B2 (AU)
Title: Improved light-emitting molecules
Inventor: DALY JOHN
IPC: C07K2/00
Filed: 2011-12-05
Granted: 2016-12-15
Abstract: Disclosed are luciferase polypeptides with improved light-emitting activity and their encoding nucleic acids. These molecules are useful in a range of assays including luciferase-based gene reporter assays, bioluminescence resonance energy transfer assays, protein complementation assays and other applications in which luciferase enzymes are utilized as detectable and/or quantifiable labels. Also disclosed are methods and compositions for increasing the sensitivity and/or improving the kinetics of luciferase-catalyzed reactions as well as decreasing the impact of undesirable variables.
Patent AU-2011351946-B2 (AU)
Title: Nucleic acid molecules that target the vacuolar ATPase C subunit and confer resistance to coleopteran pests
Inventor: NARVA KENNETH E
IPC: C12N15/12
Filed: 2011-12-30
Granted: 2017-05-18
Abstract: This disclosure concerns nucleic acid molecules and methods of use thereof for control of coleopteran pests through RNA interference mediated inhibition of target coding and transcribed non coding sequences in coleopteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of coleopteran pests, and the plant cells and plants obtained thereby.
Patent AU-2011367793-B2 (AU)
Title: Ditching apparatus with divergent V-wing blade configuration
Inventor: PENNER JEFFREY RYAN
IPC: E02F3/76
Filed: 2011-12-08
Granted: 2016-04-21
Abstract: A ditching apparatus features front blade sections fixed to the frame in a V-configuration, and a pull tongue extending over the blade apex to a pivotal connection near a rear of the frame. An actuation mechanism effects relative pivoting between the frame and the pull tongue to adjust an angle between the front blade and the trailer tongue to control a ground-penetration depth of the blade apex. Two rear blade sections on opposing sides of the frame are movable between deployed positions extending rearwardly and laterally outward from the front blade sections, and stowed positions elevated out of the deployed positions. The blade angle and width are thus controllable to achieve a desired depth and width of ditch. A nose cap at the blade apex provides an improved ground breaking action, while internally braced blade structures will roll formed skins provide durability and smooth rolling action of displaced earth.
Patent AU-2012201466-B2 (AU)
Title: Code Transformation
Inventor: TONKIN ALBERT DONALD
IPC: G06F9/45
Filed: 2012-03-12
Granted: 2014-07-03
Abstract: Abstract The invention concerns the transformation of executable code from one language to another. In particular, the invention concerns the automated transformation of code. The invention concerns methods, software and computer systems for the creation of a tree comprised of nodes to be used in the transformation of code. The invention also concerns the methods, software and computer systems for the building of a parser to be used in the transformation of code. Finally, the invention also concerns an automated and iterative method of transforming, assessing and re-transforming code. The invention is advantageous in its ability to avoid usage of an intermediate transformation language, and its high level of automation that reduces manual transformation and accordingly is more efficient and less costly. oo LL CDa m 2 0Fig. 3
Patent AU-2012201651-B2 (AU)
Title: Medical effector system
Inventor: MARTIN JAMES F
IPC: A61M31/00
Filed: 2012-03-20
Granted: 2013-01-31
Abstract: Abstract A sedation delivery system comprising: a) a microprocessor-based bedside monitoring unit having a bedside monitoring-unit host controller which contains a first program which performs the 5 steps of: issuing a request to a non-sedated patient for a non-sedated patient response; receiving a signal based on the non-sedated patient response; and calculating a non sedated response time for the patient based at least in part on a time difference between issuing the request and receiving the signal; b) a microprocessor-based procedure room unit having a procedure-room-unit 10 host controller which contains a second program which performs the steps of: issuing requests through the bedside monitoring unit to a sedated patient for a sedated patient response; receiving a signal through the bedside monitoring unit based on the sedated patient response; calculating a sedated response time for the sedated patient, and calculating a response time difference between the non-sedated and sedated response 15 times; and c) an umbilical cable having a first end attached or attachable to the bedside monitoring unit and having a second end attached or attachable to the procedure room unit, wherein at least one of the first and second ends is detachable from the corresponding bedside monitoring unit or the procedure room unit.
Patent AU-2012201703-B2 (AU)
Title: Accelerating walkway
Inventor: PAPAILIADIS STEVE
IPC: B66B23/08
Filed: 2012-03-20
Granted: 2015-01-22
Abstract: Abstract An accelerating walkway consisting of numerous narrow bands of conveyor each driven at a discrete velocity and arranged such that there is a substantially continuous variation in velocity across the walkway wherein the point of entry being at right angles to the longitudinal direction of the high speed walkway. U-I 0 0)0 -J 2 0 < 0 2: 0~ 4g 4 4jz a) u LU.-. (D t' Z 1 0 E )0o
Patent AU-2012204726-B2 (AU)
Title: Networking between VOIP -and PSTN- calls
Inventor: KAHN ARI
IPC: H04M3/42
Filed: 2012-01-09
Granted: 2016-09-08
Abstract: Programmatically reversing numerical line identity presented at a communications services gateway into named IP Telephony users with "prior association", delivers dynamic "reverse address resolution" switching connections from ground to cloud, permitting any conventional telephone to dial and connect to any associated IP Telephony endpoint in the world, without changes to the conventional telephone. Reversing line identity into associated named users bridges both the addressability and economic divide between mass conventional "paying" (mobile and fixed) and "free". IP Telephony networks. A system for supporting communications between a user on an IP-addressed-communications-device and a telephony subscriber device, the telephony subscriber device having a corresponding telephone number, includes: one or more service nodes configured to: receive from the user the telephone number of the telephony subscriber device and create an association from the telephone number to the user, wherein the association allows the telephony subscriber device to connect to the user.
Patent AU-2012216272-B2 (AU)
Title: High resolution ink-jet printing on edibles and products made
Inventor: WILLCOCKS NEIL A
IPC: A23G9/44
Filed: 2012-08-17
Granted: 2014-10-16
Abstract: Abstract Disclosed are methods of printing high resolution images on edible substrates with dispersed pigmented inks using a drop-on-demand ink-jet printer. Dispersed pigmented white inks useful with the inventive methods are also disclosed. White images having a resolution greater than 200 dpi can be printed on chocolate using the methods and inks disclosed herein. The inventive methods and inks may also be integrated with a consumer-driven site vending or e-commerce application in which the consumer provides the image to be printed and edibles bearing the printed image are prepared for rapid turnaround.
Patent AU-2012245057-B2 (AU)
Title: Improvements to tapping point clearing apparatus
Inventor: SAUER HANS ERNST
IPC: B08B1/00
Filed: 2012-03-14
Granted: 2014-06-12
Abstract: A process tapping point clearing apparatus (10) has a ram housing a piston (25) in a cylinder (12). A piston shaft (22) has a threaded first end (30) threadingly engaged with the piston. A second end of the shaft retains a clearing head extending from the cylinder, the clearing head adapted to pass through a process tapping point for removing scaling and/or debris material therefrom. The threaded first end of the shaft has an outer thread (36) diameter substantially the same as the diameter of the adjacent intermediate portion of the shaft. The piston can have a threaded aperture (44) to receive an release tool (45) to retract the piston and tapping point clearing toll (34) if stuck in an extended position.
Patent AU-2012279089-B2 (AU)
Title: Methods for the ozonolysis of organic compounds
Inventor: FITCH FRANK R
IPC: B01D53/22
Filed: 2012-07-03
Granted: 2017-02-02
Abstract: A method for producing ozone for use in ozonolysis reactions. Oxygen is separated from the mixture of ozone and oxygen from an ozone generation unit and is fed back to the oxygen feed to the generation unit. Nitrogen is fed to the ozone separation unit and the mixture of nitrogen and ozone is fed to the ozonation reactor where the ozone will react with organic compounds to produce desired end products.
Patent AU-2012286816-B2 (AU)
Title: Production of DHA and other LC-PUFAs in plants
Inventor: WALSH TERENCE A
IPC: A23L11/00
Filed: 2012-07-26
Granted: 2017-04-13
Abstract: The invention provides recombinant host organisms genetically modified with a polyunsaturated fatty acid (PUFA) synthase system and one or more accessory proteins that allow for and/or improve the production of PUFAs in the host organism. The present invention also relates to methods of making and using such organisms as well as products obtained from such organisms.
Patent AU-2012296501-B2 (AU)
Title: Preconnectorized cable assemblies for indoor/outdoor applications
Inventor: KLAVUHN TORY ALLEN
IPC: G02B6/36
Filed: 2012-08-16
Granted: 2015-11-26
Abstract: Fiber optic cable assemblies having a preconnectorized hardened connector on at least one end of a fiber optic cable that includes a subunit cable surrounded by an upjacketed portion having strength components and method for making are disclosed. The subunit cable has the optical fiber and a plurality of tensile yarns disposed within a subunit jacket. The hardened connector is attached to the optical fiber at a first end and strain-relieves at least some of the plurality of tensile yarns and the strength components. The cable assembly may also include a non-hardened connector on the second end of the optical fiber along with an optional pulling grip.
Patent AU-2012312056-B2 (AU)
Title: Automatic injection device
Inventor: SHANG SHERWIN S
IPC: A61M5/20
Filed: 2012-09-21
Granted: 2017-11-16
Abstract: Automatic injection device includes a housing, a syringe, a plunger, and a syringe carrier. The housing includes a barrel between a first end and a second end. The barrel includes an elongated window to allow viewing of contents inside the housing. The syringe is disposed within the housing and has a reservoir. The plunger is at least partially disposed within the syringe and includes a visual indicator. The syringe carrier is disposed within the housing and configured to contain the syringe and displace the syringe within the housing between a first position and a second position. The syringe carrier can be substantially transparent. The syringe carrier can have first and second legs and an extension disposed therebetween, and at least a portion of the extension can be configured to align with the window and the reservoir when the syringe carrier is in the first position.
Patent AU-2012332715-B2 (AU)
Title: Apparatus and method for generating metal ions in a fluid stream
Inventor: HUBRIG JEFFREY G
IPC: B01D61/44
Filed: 2012-10-31
Granted: 2016-10-20
Abstract: An apparatus for providing metal ions to a fluid waste stream includes a housing having an inlet port and an outlet port through which the fluid waste stream enters and exits the housing. Within the housing and between the inlet and outlet ports is an electrode assembly that includes first electrode ring assemblies and second electrode ring assemblies. Each first electrode ring assembly includes a first tubular section formed of electrically insulative material and has an interior through which the fluid waste stream flows. One or more first electrode plates span the interior of the first tubular section and contact the fluid waste stream. Each second electrode ring assembly includes a second tubular section formed of electrically insulative material and has an interior through which the fluid waste stream flows. One or more second electrode plates span the interior of the second tubular section and contact the fluid waste stream. The first tubular sections of the first electrode ring assemblies are in fluid communication with the second tubular sections of the second electrode ring assemblies.
Patent AU-2012351504-B2 (AU)
Title: Biomarkers and parameters for preeclampsia
Inventor: THOMAS GREGOIRE
IPC: G01N33/68
Filed: 2012-12-14
Granted: 2018-01-04
Abstract: The application discloses new test panels comprising biomarkers and clinical parameters, for the prediction, diagnosis, prognosis and/or monitoring of hypertensive disorders of pregnancy and particularly preeclampsia; and related methods, uses, kits and devices.
Patent AU-2013200595-B2 (AU)
Title: Laser-based supercooled large drop icing condition detection system
Inventor: MEIS CHARLES STEVEN
IPC: G01N21/17
Filed: 2013-02-01
Granted: 2016-07-07
Abstract: LASER-BASED SUPERCOOLED LARGE DROP ICING CONDITION DETECTION SYSTEM A method and apparatus for detecting icing conditions. An icing condition detection system comprises a number of sensors (626) and an icing condition detector. The number of sensors (626) is located in a number of locations (632) on an aircraft (612). A sensor in the number of sensors (626) is configured to emit electromagnetic radiation (627) into drops (638) of water in an environment around the aircraft (612). The sensor in the number of sensors (626) is configured to detect responses to the electromagnetic radiation (627). The sensor in the number of sensors (626) is configured to generate data from the responses. The icing condition detector is configured to monitor for the data from the number of sensors (626). The icing condition detector is further configured to detect a presence of a number of types of icing conditions for the aircraft (612) using the data from the number of sensors (626). C) '0 J \\ CCj
Patent AU-2013205253-B2 (AU)
Title: Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
Inventor: WILLIAMS JEFF
IPC: C12Q1/68
Filed: 2013-04-10
Granted: 2015-07-02
Abstract: HAsp\lnicrnotn\NRPonbl\DC.IXP\506Io4_ .DOC-9/2011 A diagnostic apparatus, comprising: a first module configured to extract nucleic acid simultaneously from a plurality of nucleic-acid containing samples, wherein the first module comprises: one or more racks, each configured to accept a number of samples and a corresponding number of holders, wherein each holder comprises a process chamber, a waste chamber, one or more pipette tips, and one or more receptacles, wherein the one or more receptacles contain respectively sufficient quantities of one or more reagents for carrying out extraction of nucleic acid from a sample; a magnetic separator configured to move relative to the process chambers of' each holder; a heater assembly configured to independently heat each of the process chambers; and a liquid dispenser configured to carry out fluid transfer operations on two or more holders simultaneously; and a second module configured to simultaneously amplify the nucleic acid extracted from the plurality of samples, wherein the second module comprises: one or more bays, each configured to receive a microfluidic cartridge, wherein the cartridge is configured to separately accept and to separately amplify the nucleic acid extracted from multiple samples; and one or more detection systems.
Patent AU-2013206258-B2 (AU)
Title: System and method for protecting gasifier quench ring
Inventor: BHATTACHARYA PAROMITA
IPC: C10J3/72
Filed: 2013-06-11
Granted: 2017-04-20
Abstract: SYSTEM AND METHOD FOR PROTECTING GASIFIER QUENCH RING A system includes a gasifier. The gasifier includes a reaction chamber configured to convert a feedstock into a synthetic gas, a quench chamber configured to cool the synthetic gas, and a transition section between the reaction chamber and the quench chamber. The gasifier also includes a quench ring configured to provide a first flow of a coolant to the quench chamber and a shielding gas system configured to provide a second flow of a shielding gas to protect at least one of the quench ring or the transition section. C)) 000 K. = ____
Patent AU-2013209310-B2 (AU)
Title: Composition comprising egg white-chalcanthite for preventing or treating cancer
Inventor: CHOI EUN A
IPC: A61K33/34
Filed: 2013-07-24
Granted: 2016-06-23
Abstract: The present invention relates to compositions for preventing and treating cancer containing egg whites combined with blue vitriol. More specifically, the present invention relates to: the 5 compositions which comprise the detoxified egg whites combined with blue vitriol individually, or together with the mixture of bamboo salts and egg whites combined with blue vitriol, wherein the egg whites combined with blue vitriol are produced by mixing egg whites with blue vitriol; and a preparation method thereof. The compositions containing the egg whites combined with blue vitriol have improved anticancer activity, and therefore can 10 be valuably used for a pharmaceutical preparation for preventing and treating cancer and manufacturing functional health food.
Patent AU-2013229578-B2 (AU)
Title: Biocontrol
Inventor: ALPHEY LUKE
IPC: A01K67/033
Filed: 2013-03-05
Granted: 2017-07-20
Abstract: Provided is an arthropod male germline gene expression system suitable for conditional expression of an effector gene in an Arthropod male germline. The system comprises a first expression unit comprising an effector gene and a promoter therefor operably linked thereto; and a second expression unit. Said second unit comprises a coding sequence for a transcription factor and an upstream regulatory element operably linked thereto, the transcription factor being capable of acting upon the promoter in the first expression unit to drive expression of the effector gene. The upstream regulatory element includes a promoter for the transcription factor; and a 5' UTR adjacent a start site for the transcription factor coding sequence. The upstream regulatory element driving sufficient expression of the transcription factor such that the transcription factor protein in turn drives transcription of the effector gene before meiosis. Also provided are uses of the system for instance in methods of biocontrol and quality control.
Patent AU-2013248301-B2 (AU)
Title: Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
Inventor: GARCIA ANTON JOSE MARIA
IPC: C07K7/06
Filed: 2013-04-16
Granted: 2017-11-09
Abstract: Compounds of general formula (I): R
Patent AU-2013258028-B2 (AU)
Title: Ultrasound contact fluid
Inventor: SELBEKK TORMOD
IPC: A61K49/22
Filed: 2013-05-08
Granted: 2018-06-14
Abstract: The present invention concerns an aqueous ultrasound contact fluid comprising a pharmaceutical grade triglyceride and a pharmaceutically acceptable emulsifier and the use of said ultrasound contact fluid in an intraoperative or interventional ultrasound imaging procedure.
Patent AU-2013263159-B2 (AU)
Title: Treatment of amd using AAV sFlt-1
Inventor: CONSTABLE IAN J
IPC: A61K39/00
Filed: 2013-05-07
Granted: 2018-05-31
Abstract: The present disclosure provides compositions and methods for the prevention or treatment of ocular neovascularization, such as AMD, in a human subject, by administering subretinally a pharmaceutical composition comprising a pharmaceutically effective amount of a vector comprising a nucleic acid encoding soluble Fms-related tyrosine kinase- 1 (sFlt-1) protein to the human subject.
Patent AU-2013285456-B2 (AU)
Title: Brassica ROD1 gene sequences and uses thereof
Inventor: DENOLF PETER
IPC: C12Q1/68
Filed: 2013-07-04
Granted: 2018-08-02
Abstract: The present invention relates to Brassica juncea ROD1 nucleic acid sequences and proteins and the use thereof to create plants with increased levels of C1 8: 1 and reduced levels of saturated fatty acids in the seeds.
Patent AU-2013304813-B2 (AU)
Title: Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Inventor: BELL NOAH
IPC: A61P9/04
Filed: 2013-08-20
Granted: 2016-08-04
Abstract: The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist- induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.
Patent AU-2013323472-B2 (AU)
Title: Glycosidase regimen for treatment of infectious disease
Inventor: KLINE ELLIS
IPC: A01N25/00
Filed: 2013-09-26
Granted: 2018-07-05
Abstract: In various aspects, the invention relates to immune tolerant glycosidase therapy. The invention provides methods for treating or preventing infectious disease, including chronic viral infections, and highly contagious infectious agents that present an ongoing challenge for the immune system. The compositions and treatment regimens find use with other antiviral or antimicrobial therapies, as well as in conjunction with vaccination to boost effectiveness and/or extend the duration of protective effect. In certain embodiments, the regimen described herein reduces or eliminates the need for administration of other traditional antiviral or antimicrobial therapies. In various embodiments, the invention finds use in immunocompromised patients to boost immune function.